companydata.dkNORDIC BIOTECH PRIVATE INVESTORS ApS: Financial statements 2023
CVR: 26284384
NORDIC BIOTECH PRIVATE INVESTORS ApS (CVR 26284384) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 49,468 and a net result of DKK -7,687 compared with DKK -1,036,850 the year before. Equity amounted to DKK 1,466,758. The solvency ratio was 98.7%.
- Gross Profit
- 49,468 kr.
- Profit/Loss
- -7,687 kr.
- Equity
- 1,466,758 kr.
- Total Assets
- 1,485,633 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 49 t. | -8 t. | 1.5 mio. | - |
| 2022 | - | -20 t. | -1 mio. | 1.5 mio. | 0 |
| 2021 | - | -15 t. | -168 t. | 2.5 mio. | 0 |
| 2020 | - | -16 t. | -55 t. | 2.7 mio. | - |
| 2019 | - | -29 t. | 262 t. | 2.7 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
NORDIC BIOTECH PRIVATE INVESTORS ApS has published its annual report for 2022. Gross profit came to DKK -20,000, and the net result was DKK -1,036,850.
About NORDIC BIOTECH PRIVATE INVESTORS ApS
NORDIC BIOTECH PRIVATE INVESTORS ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company was registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Mosegaard Larsen. The company's owners include Thue Walter Schwartz, Peter Moldt and Dorte Kloppenborg Skrumsager. In 2025, the company reported a gross profit of DKK -432,293 and a net result of DKK -571,396 compared with DKK 2,080,087 the year before. Equity amounted to DKK 2,975,449.